News from NORD

Presentation Chronicles Pathway to Erdheim-Chester Diagnosis


 

At the American College of Rheumatology’s Clinicopathologic Conference, a team of four physicians from the National Institutes of Health and George Washington University presented a case study of a rare inflammatory disease and the series of imaging and pathology tests they conducted to arrive at the diagnosis of Erdheim-Chester disease.

Recommended Reading

Free Webinar Planned for Those Interested in Referring or Applying to NIH Undiagnosed Diseases Network
MDedge Endocrinology
NORD to Develop Natural History Studies With 20 Rare Disease Patient Organizations
MDedge Endocrinology
$6.8 Million Awarded to Study the Biology of Rare and Undiagnosed Diseases
MDedge Endocrinology
Beloranib reduces weight in Prader-Willi syndrome, but concerns remain
MDedge Endocrinology
Adrenal gland tumors linked to ADHD diagnosis
MDedge Endocrinology
Enlist appropriate psychological consults for gender dysphoria
MDedge Endocrinology
Study identifies important predictors for PC/PGL
MDedge Endocrinology
European Commission’s proposed criteria for endocrine disruptors trigger multiple concerns
MDedge Endocrinology
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Endocrinology
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Endocrinology